iShares launch US medical devices ETF

Abbott Laboratories among 50 holdings

James Baxter-Derrington
clock • 1 min read

iShares has launched an ETF focusing on medical device manufacturers in the US to provide a targeted approach to healthcare investing.

The iShares US Medical Devices UCITS ETF (UMDV) offers investors exposure to a "broad range of US companies involved in the manufacturing and distribution of medical devices" and is available for a total expense ratio of 0.25%. BlackRock launches ultra-short ESG bond ETFs It tracks the Dow Jones US Select Medical Equipment Capped 35/20 index, which is comprised of companies in the US Healthcare GICS sector, capped to "ensure diversification" within the index. The ETF debuted with approximately 59 holdings, of which the largest, Abbott Laboratories and Thermo Fisher Scientific, cons...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on ETFs

7IM's Ben Kumar: The debate around the passive pendulum swinging too far

7IM's Ben Kumar: The debate around the passive pendulum swinging too far

'A catastrophic event' highly unlikely

Ben Kumar
clock 05 December 2024 • 4 min read
Robeco makes range of active ETFs available to UK market

Robeco makes range of active ETFs available to UK market

Previously only available on Frankfurt and Swiss exchanges

Eve Maddock-Jones
clock 04 December 2024 • 2 min read
WisdomTree's Alexis Marinof: The greatest innovations in ETFs are still ahead

WisdomTree's Alexis Marinof: The greatest innovations in ETFs are still ahead

'Increased adoption, more investor choice'

Alexis Marinof
clock 03 December 2024 • 3 min read
Trustpilot